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Flucytosine, CAS #2022-85-7, crystallizes in the tetragonal space group P41212 (#94) with a =
6.643768(27), c = 23.89009(10) Å, V = 1054.500(7) Å3, and Z = 8. In this work, the sample was
obtained from the United States Pharmacopeial Convention (USP) Lot #R03100 and analyzed
as-received. The room temperature (295 K) crystal structure was reﬁned using synchrotron (λ =
0.412826 Å) powder diffraction data and optimized using the density functional theory (DFT).
When looking down the a-axis, the crystal structure consists of multiple ribbon-like structures stacked
into columns. The powder X-ray diffraction pattern of the compound has been submitted to ICDD®
for inclusion in the Powder Diffraction File™ (PDF®). The agreement of the Rietveld-reﬁned and
DFT-optimized structures is good, with the largest difference in the external amine group with an
overall root mean displacement of 0.056 Å. There is also evidence of unit cell expansion at higher
temperatures, as the volume of the unit cell at 298 K was 1.6–1.9% greater than the two unit cells
obtained at 150 K. A N–H⋯O hydrogen bond exists in the inter-ribbon region between the ﬂucytosine molecules, resulting in a 3D hydrogen bond network. © 2020 International Centre for Diffraction
Data. [doi:10.1017/S0885715619000903]
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Flucytosine, also called 5-ﬂuorocytosine (commercial name
Ancobon), is an antifungal drug used to treat Candida
(yeast) and cryptococcosis infections. Flucytosine, CAS
#2022-85-7, crystallizes in the tetragonal space group
P41212 (#94) with a = 6.643768(27), c = 23.89009(10) Å,
V = 1054.500(7) Å3, and Z = 8. A reduced cell search in the
Cambridge Structural Database (Groom et al., 2016) yielded
one previous structure determination (Hulme and Tocher,
2006), using single-crystal X-ray diffraction collected at
150 K. A powder pattern calculated from this crystal structure
is included in the Powder Diffraction ﬁle as entry
02-090-1047. Powder diffraction patterns calculated from
low-temperature, single-crystal data typically have diffraction
peaks with 2θ positions that differ from room temperature
powder diffraction data. These differences subsequently hinder phase identiﬁcation at room temperature, thus the need
for high-quality, room temperature X-ray diffraction data
(Kaduk et al., 2014).
In this work, the sample was obtained from the United
States Pharmacopeial Convention (USP) Lot #R03100 and
analyzed as-received. The diffraction data were collected on
beamline 11-BM at the Advanced Photon Source at
Argonne National Laboratory. The room temperature (295
K) crystal structure was reﬁned using synchrotron (λ =
0.412826 Å) powder diffraction data and optimized using
the density functional theory (DFT). Hydrogen positions
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were also included as a part of the structure and were
re-calculated during the reﬁnement (Figure 1).
The agreement of the Rietveld-reﬁned and DFToptimized structures is good, with the largest difference in
the external amine group with an overall root-mean-squared
displacement of 0.056 Å. When looking down the a-axis,
the crystal structure consists of multiple ribbon-like structures
stacked into columns. There is also evidence of unit cell
expansion at higher temperatures, as the volume of the unit
cell at 295 K was 1.6–1.9% greater than the unit cells obtained
at 150 K. We noticed similar hydrogen bonding between the
structures at 150 K and 298 K. Speciﬁcally, we also found the
N1–H2⋯O1 hydrogen bond that exists in the inter-ribbon region
between the ﬂucytosine molecules, resulting in a 3D hydrogen
bond network. The powder X-ray diffraction pattern of the compound has been submitted to ICDD® for inclusion in the Powder
Diffraction File™ (PDF®; Gates and Blanton, 2019).
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Figure 1. (Colour online) Powder X-ray diffraction pattern of ﬂucytosine. The Rietveld reﬁnement structure is indicated in red, and the DFT-optimized structure
is indicated in blue.

DEPOSITED DATA

CIF and/or RAW data ﬁles were deposited with ICDD.
You may request this data from ICDD at info@icdd.com.
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